Europe is anticipated to capture nearly one-third of the global High Performance Liquid Chromatography (HPLC) market, growing at a CAGR of 4.4%

This wide array of applications are anticipated to bolster prospects for the global high performance liquid chromatography market during the forecast period (2020-2026). Anticipated CAGR during this period is pegged at 5.4%. High Performance Liquid Chromatography (HPLC) is a highly sophisticated and an expensive technique, used to separate and identify various compounds in liquids and tissues.
HPLC techniques have been widely used in food processing, clinical diagnosis and forensic sciences. The technique is commonly used for drug analysis, separation of molecules and environmental control. The recent COVID-19 pandemic is poised to moderately impact testing volumes due to a number of the key companies’ employees practicing social distancing. Nevertheless, overall growth prospects shall remain positive.

Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4791

Key Takeaways of Global HPLC Market Study:

• By product type, the instruments segment is poised to be leveraged the maximum in the global HPLC market. This is attributed to the reduction in the usage of detectors and pumps in favor of more accurate and precise instruments. The segment is anticipated to capture more than 2/5th of the overall market.
• By end-users, pharmaceutical & biotechnology industry and diagnostic laboratories segments shall grow at a CAGR of 5.7% each, burgeoned by increased government initiatives to fund small-scale industries and entry of existing market players and the rising prevalence of chronic diseases.
• The food and beverage industry shall expand rapidly, owing to the increasing demand for nutritious food and better packaging. The segment is poised to expand 1.4x, capturing more than 1/5th of the global HPLC market.
• By region, Europe is anticipated to capture nearly one-third of the global HPLC market, growing at a CAGR of 4.4%. Increasing investments by key players in the pharmaceutical and biotechnology industry, as well as government intervention in the field of environmental control and food safety is poised to leverage the region’s growth.

For information on the Research Approach used in the Report, Request Methodology@ https://www.factmr.com/connectus/sample?flag=RM&rep_id=4791

• Asia-Pacific shows promising growth prospects. This is attributed to increasing investments by key players in clinical research and development of new drugs to provide innovative treatment options. A CAGR of 5.3% is predicted for the region.

“The global HPLC market is poised to expand on a positive growth trajectory in the future. The wide range of applications of HPLC techniques has prompted key players to invest heavily in strengthening their product portfolios to offer novel solutions. While the COVID-19 pandemic may limit the volumes of testing, the overall growth trend is poised to remain elevated,” interprets a Fact.MR analyst.

Global HPLC Market: Research and Development Initiatives to Define Competition Landscape
The global HPLC market comprises of the following players: Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Waters Corporation, GE Healthcare, Shimadzu Corporation, PerkinElmer Inc., Gilson, Inc., and Phenomax, Inc., to name a few. These companies have invested in strengthening their product portfolio and research and development operations.

Waters Corporation is a leading life sciences company which designs, develops and markets liquid chromatography instruments, such as the Alliance HPLC System which provides advanced solvent delivery capabilities. Similarly, Agilent Technologies specializes in three categories of HPLC systems: Analytical, Application-Specific and Preparative Systems.

Get Full Access of the Report @ https://www.factmr.com/checkout/4791/S

COVID-19 Market Insights:

The leading players in the HPLC market consider the well-being of their staff of primary importance. Most players like Agilent Technologies have established business continuity plans (BCPs) to ensure that their production does not fall behind. The BCPs cover the physical infrastructure of the site, supply-chain disruptions and logistics.
The company has a diversified supply chain which helps guarantee surety of supply. While most of the workforce operates from home, there are a few workers who have to work on-site. For them, additional precautionary measures are being taken by leading players such as increased cleaning and disinfection, screening and restricted access for visitors and availability of personal protective equipment.

Looking for more information?

The research study on the global high performance liquid chromatography (HPLC) market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global blood transfusion diagnostics market over 2020-2026. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2026. Market statistics have been presented on the basis of Product Type (Instruments, Consumables and Accessories) and End-user (Pharmaceutical & Biotechnology Industries, Diagnostic Laboratories, Food & Beverage Industry, Academic and Research Institutes and Others) across five major regions.

Fact. MR’s Domain Knowledge in Healthcare

Fact .MR’s healthcare and research professionals guide organizations at each step of their business strategy by helping you understand how contemporary influencers impact transformation in the healthcare sector. Our expertise in recognizing the challenges and trends affecting the global healthcare industry provides valuable insight and support, helping identify critical issues and construct relevant solutions.

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Website : https://www.factmr.com

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.